Medicare beneficiaries will see major pricing shifts as federal negotiations reshape how costly prescription drugs are paid ...

The list of drugs seeing a price cut for Medicare recipients is increasing — some cancer meds are set to drop by thousands.

Medicare has locked in lower prices on a slate of heavily used prescription drugs, a shift that will ripple through household ...

Medicare prescription drug costs are entering a new phase in 2026, and for millions of beneficiaries the changes could ...

The savings go into effect in 2027 and are expected to save billions for government health program.

Medicare beneficiaries spent $1.7 billion out of pocket on the 15 drugs. The negotiated price reductions may save beneficiaries $685 million in out-of-pocket costs.

There is no sole Medicare drug price list currently available, as medication costs and availability can vary according to the company administering a Part D prescription drug plan. A person must ...

The Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on those medications compared with recent annual spending, or about $8.5 billion in ...

The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and Astellas Pharma Inc. that will face a 48% discount off its 2024 list price. GSK ...

A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...

The IRA requires health plans serving the Part D market to cover all negotiated drugs, and it has been predicted that CMS ...

Confused about Medicare Part D? Explore essential insights that clearly explain how it works, what it covers, and how to ...